Don’t let the cost of IBS-C or chronic constipation treatment put your quality of life at risk. We help eligible patients access brand-name Linzess for $69.95 per month through the manufacturer’s Patient Assistance Program.
The Linzess Prescription Assistance Program is a manufacturer-sponsored initiative run by AbbVie that provides brand-name Linzess at no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, and it may also accept Medicare patients on a case-by-case basis. If approved, you can receive up to 12 months of medication at no charge, with the option to reapply as needed. The challenge is that applying on your own can be confusing and time-consuming. Eligibility requirements, documentation needs, and program protocols differ — and they can change without notice. AffordMyPrescriptions eliminates that burden entirely. For a flat $69.95 per month, our Patient Advocates
manage every step of your enrollment, from initial application to annual re-enrollment, so you can focus on managing your condition instead of managing paperwork.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$298.65 | Save ~$229/mo |
| CVS Pharmacy | ~$305.02 | Save ~$235/mo |
| Walmart | ~$299.23 | Save ~$229/mo |
| Kroger | ~$289.84 | Save ~$220/mo |
*Just a heads-up: retail prices are estimates based on public data and vary by pharmacy. Fortunately, Afford My Prescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Navigating prescription assistance programs on your own can feel like a second job. Each program has its own eligibility criteria, forms, timelines, and renewal requirements — and if you miss a step, you risk losing access to the medication you depend on. That’s exactly the kind of burden you shouldn’t have to carry when you’re already managing a chronic condition like IBS-C or CIC. At AffordMyPrescriptions, trained Patient Advocates handle every detail of your enrollment — preparing and submitting your application, coordinating with your doctor’s office, monitoring your status through every stage, and managing annual re-enrollment proactively. Your cost is a flat $69.95 per month — no surprises, no annual caps, no co-pay accumulators. If we’re unable to secure your medication, you won’t be charged.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
GoodRx and SingleCare coupons provide genuine savings on Linzess, and the the manufacturer’s Linzess Savings Program offers $30/month for commercially insured patients. But each has significant limitations for a daily, long-term medication. Here’s why the PAP through AffordMyPrescriptions is the better solution for those who qualify:
You may be eligible for the Linzess Patient Assistance Program (AbbVie) if you meet the following general criteria:
Living with IBS-C or chronic idiopathic constipation can feel exhausting — unpredictable abdominal pain, bloating, straining, and infrequent or incomplete bowel movements that disrupt your entire day. Linzess (linaclotide) is one of the few prescription medications specifically designed to treat both the pain and the constipation of these conditions at the same time. It is available in three strengths (72 mcg, 145 mcg, and 290 mcg) and is taken once daily on an empty stomach, at least 30 minutes before your first meal. Linzess is FDA-approved for adults with IBS-C or CIC, and for children ages 6–17 with functional constipation.
How Linzess Works: Targeting the Root Cause in Your Gut
Linzess contains linaclotide, a synthetic peptide that activates a special receptor (guanylate cyclase-C) on the lining of your intestines.
When activated, it increases the secretion of chloride and bicarbonate into your intestinal tract — this draws water into the intestines, softening stool and making bowel movements easier, faster, and more complete.
It also reduces visceral pain by calming the sensitivity of pain-sensing nerves in the gut, helping relieve the abdominal discomfort that often comes with IBS-C.
Linzess works locally in your intestines and is not significantly absorbed into the bloodstream, so it delivers targeted relief with minimal systemic side effects.
Generic or Biosimilar Availability: Why Ozempic Is Still Brand-Only
As of April 2026, there is no generic or biosimilar version of Ozempic available in the United States. Because Ozempic is a biologic medication made from living cells, it cannot have a simple generic — any lower-cost option must be an approved biosimilar that goes through years of extra testing. U.S. patents protect Ozempic until at least 2031–2032, with some patents lasting even longer. This means Ozempic remains a premium brand-name product, making the manufacturer’s Patient Assistance Program the most effective way for eligible patients to get it at no medication cost.
The average retail price is approximately $580–$730 per month for 30 capsules (145 mcg), depending on the strength and pharmacy. With the best GoodRx discount coupons, you’ll pay approximately $290–$316 per month. SingleCare offers a best price of ~$252 per month at participating pharmacies. Through AffordMyPrescriptions, qualifying patients receive Linzess at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Yes. The Linzess supplied through the assistance program is the exact same brand-name, FDA-approved linaclotide capsules manufactured by AbbVie. It is identical to what any retail pharmacy would dispense.
The AbbVie assistance program does evaluate Medicare patients on a case-by-case basis. Most Medicare Part D plans cover Linzess, and the $2,100 annual out-of-pocket cap (2026) limits your total Part D drug spending. Note that the Linzess Savings Card ($30/month) explicitly excludes all Medicare patients. Contact AffordMyPrescriptions and we’ll help you determine the best pathway for your specific situation.
No. There is no FDA-approved generic version of Linzess as of April 2026. Based on patent settlement agreements, generic versions of linaclotide 145 mcg and 290 mcg are not expected until March 2029 at the earliest. The 72 mcg strength may follow by mid-2030. Until then, the AbbVie Patient AssistanceProgram is the most affordable way to access Linzess for qualifying patients.
Typically 2 to 4 weeks from completed application to first delivery. Our advocates work to expedite the process and can help you access bridge supplies or alternative savings programs if you need medication while your application is being processed.
.
If you’re struggling with the high cost of Linzess, our team can help you access assistance programs designed
to make your IBS-C or chronic constipation treatment more affordable.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.